Clinical Trial Update: Combination GRA and SGLT-2i Treatment in Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports completion of a combination therapy with GRA and SGLT-2 inhibitor in Type 1 Diabetes across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GRA
• SGLT-2 inhibitor

Snippet

Sponsor: University of California, San Diego | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED